BPA - CO - PULSE - Policy Understanding and Learning through Systematic Eva
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $3,000,000 to $7,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541618 Other Management Consulting Services
- Points of contact
-
- CTP Acquisition Liaison ctpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration's Center for Tobacco Products is seeking evaluation support services through the Policy Understanding and Learning through Systematic Evaluation (PULSE) initiative, a new requirement to be procured via Blanket Purchase Agreement. This engagement will support research efforts aimed at collecting evidence on the implementation, effectiveness, impact, and unintended consequences of domestic and international tobacco control policies, with the primary objective of enhancing FDA/CTP's understanding of regulatory reactions and informing potential future regulatory actions. The solicitation is forecasted for release on February 1, 2026, with an estimated award date of September 1, 2026.
The estimated award value ranges from $3,000,000 to $7,000,000 for this management consulting services engagement classified under NAICS 541618. This is an unrestricted procurement with no set-aside provisions applied. Interested parties should direct inquiries to the FDA's Center for Tobacco Products at ctpacquisitions@fda.hhs.gov for additional information regarding this forecasted opportunity.
Forecast text
This evaluation support call, Policy Understanding and Learning through Systematic Evaluation (PULSE), will
complement and support research that is aiming to collect evidence on the implementation,
effectiveness, impact, and unintended consequences of domestic and international tobacco control
policies. This project will increase FDA/CTP's understanding of reactions to regulations and policies related
to tobacco products and can inform the development of potential future FDA regulatory action.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast